Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-08

Clinical Trial Update: Clinical Trial of Acamprosate for Tinnitus [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating acamprosate for tinnitus, sponsored by Oregon Health and Science University, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • acamprosate (acamprosate)

Snippet

Sponsor: Oregon Health and Science University | Conditions: Tinnitus | Phase 1 | Status: COMPLETED